Bifidobacteria

There is increasing awareness that the human gut microflora plays a critical role in maintaining host health, both within the gastrointestinal tract and, through the absorption of metabolites, systemically. An optimal gut microflora establishes an efficient barrier to the invasion and colonisation of the gut by pathogenic bacteria, produces a range of metabolic substrates which in turn are utilized by the host (e.g. vitamins and short chain fatty acids) and stimulates the immune system in a non-inflammatory manner. Although little is known about the individual species of bacteria responsible for these beneficial activities, it is generally accepted that the bifidobacteria and lactobacilli constitute important components of the beneficial gut microflora. A number of diet-based microflora management tools have been developed and refined over recent decades including probiotic, prebiotic and synbiotic approaches. Each aims to stimulate numbers and / or activities of the bifidobacteria and lactobacilli within the gut microflora. The aim of this article is to examine how prebiotics are being applied to the improvement of human health and to review the scientific evidence supporting their use.

A number of studies involving the feeding of probiotics and prebiotics to infants have been published over the last decade. These studies have examined a wide range of health outcomes, including growth and safety, prophylaxis and alleviation of diarrheal disease, reduction in atopic disease, reduction in necrotizing enterocolitis, and reduction in infection of the preterm infant. In addition, these studies have described microbiological alterations observed in response to probiotic and prebiotic feeding. Collectively, the reports demonstrate that probiotics show considerable promise in addressing several health outcomes of significance to both formula-fed and breastfed infants. As quantitative and qualitative differences appear to exist between the microfloras of human-milk fed and formula-fed infants, recent innovations to infant formula have involved the inclusion of probiotics and prebiotics as a means of making the flora of the formula fed infant more similar to that of the breastfed infant. To date, only a few probiotic- and prebiotic-containing infant formulas have been marketed, but as new safety and efficacy data emerge and the regulatory climate becomes more favourable, the number of products is expected to grow.

Diabetes mellitus is considered a global health problem which affects all sections of society, creating health and economyhardships. A large number of studies have identified risk factors that cause metabolic disorders such as genetic predisposition, unhealthy lifestyle, and altered gut microbiota. These factors are responsible for causing an increased adiposity, b-cell dysfunction, hyperglycemia, hypercholesterolemia, adiposity, dyslipidaemia, systemic inflammation, defective secretion of incretins and oxidative stress associated with type-2 diabetes (T2D). Probiotics particularly lactobacilli and bifidobacteria have recently emerged as the potentialtherapeutic agents with proven efficacy demonstrated in various in vitro and in vivo animal models adequately supported with their established multifunctional roles and mechanism of action for the prevention and disease treatment. The dietary management of DM by using probiotics is considered a novel strategy to slow development and progression of DM. Altering gut microbial composition holdsa significant potential for prevention and treatment of DM. This review will highlight the new developments in probiotic interventions and future prospects for exploring probiotic therapy in the prevention and management of DM.

Bifidobacterium bifidum and Bifidobacterium infantis were added to mayonnaise as either free cells or encapsulated. The survival of bifidobacteria and their effect on mayonnaise quality were evaluated. The viability of free cells disappeared after 2 wk; however, encapsulated B. bifidum survived well for 12 and B. infantis for 8 wk. Mayonnaise containing encapsulated bifidobacteria had lower total bacterial counts compared to other treatments. Yeast and mold started to appear after 12 wk of storage in mayonnaise containing encapsulated bifidobacteria and after 6 wk with other treatments (control, cells free of bifidobacteria). Mayonnaise containing encapsulated bifidobacteria had higher titratable acidity and lower TBA values than other treatments. Sensory properties of mayonnaise were improved by the addition of encapsulated bifidobacteria.

Obesity is now classically characterized by a cluster of several metabolic disorders, and by a low grade inflammation. The evidence that the gut microbiota composition can be different between healthy and or obese and type 2 diabetic patients has led to the study of this environmental factor as a key link between the pathophysiology of metabolic diseases and the gut microbiota. Several mechanisms are proposed linking events occurring in the colon and the regulation of energy metabolism, such as i.e. the energy harvest from the diet, the synthesis of gut peptides involved in energy homeostasis (GLP-1, PYY … ), and the regulation of fat storage. Moreover, the development of obesity and metabolic disorders following a high-fat diet may be associated to the innate immune system. Indeed, high-fat diet feeding triggers the development of obesity, inflammation, insulin resistance, type 2 diabetes and atherosclerosis by mechanisms dependent of the LPS and/or the fatty acids activation of the CD14/TLR4 receptor complex. Importantly, fat feeding is also associated with the development of metabolic endotoxemia in human subjects and participates in the low-grade inflammation, a mechanism associated with the development of atherogenic markers. Finally, data obtained in experimental models and human subjects are in favour of the fact that changing the gut microbiota (with prebiotics and/or probiotics) may participate in the control of the development of metabolic diseases associated with obesity. Thus, it would be useful to find specific strategies for modifying gut microbiota to impact on the occurrence of metabolic diseases.

Background: Dietary amylose resists enzymatic digestion, thereby providing a substrate for microbial fermentation that stimulates proliferation of beneficial microbiota and production of short-chain fatty acids (SCFAs) in the large intestine of pigs and humans. However, the effect of increasing dietary amylose in pigs immediately postweaning on growth, nutrient digestibility and flow, and intestinal microbial and SCFA profiles has not been studied and can be used as a model for newly weaned human infants.
Objective: We studied the effects of increasing dietary amylose on growth, nutrient digestibility, and intestinal microbial and metabolite profiles in weaned pigs.
Methods: Weaned pigs (n = 32) were randomly allocated to 1 of 4 diets containing 67% starch with 0%, 20%, 28%, or 63% amylose for 21 d. Subsequently, pigs were killed to collect feces and digesta for measuring starch digestion and microbial and metabolite profiles.
Results: Feeding weaned pigs 63% compared with 0%, 20%, and 28% amylose decreased (P < 0.05) feed intake by 5% and growth by $12%. Ileal digestibility of dry matter decreased (P < 0.05) by 10% and starch by 9%, thereby increasing (P < 0.05) hindgut fermentation, cecal and colonic total SCFAs, and colonic Bacteroides, and lowering (P < 0.01) ileal, cecal, and colonic pH in pigs consuming 63% compared with 0%, 20%, and 28% amylose. Cecal and colonic Bifidobacteria spp. increased by 14–30% (P < 0.05) and Clostridium clusters IV and XIVa were decreased (P < 0.01) in pigs consuming 63% compared with 0%, 20%, and 28% amylose.
Conclusion: Increasing dietary amylose in pigs immediately postweaning stimulated hindgut fermentation and Bifidobacteria spp., thereby manipulating the gut environment, but also reduced intake and growth. An optimum dietary amylose concentration should be determined, which would maintain desired growth rate and gut environment in weaned pigs.

This study aims to investigate the effect of fructooligosaccharide (FOS) (0.5, 1, 2, 3, and 4%) supplementation on the growth and survival of Bifidobacterium breve and Bifidobacterium longum in glucose, fructose, lactose, and sucrose (2, 3, and 4%) systems with 24-h growth and 10-day survival assays at 37°C. FOS supplementation showed a higher growth-promoting effect on B. longum than B. breve in various sugar systems. The highest percentage of increase in growth index, 78.5%, was observed with 4% sucrose supplemented with 0.5% FOS in B. longum. In comparison, the highest percentage increase in growth index, 5.6 and 6.6%, was observed in the presence of 2% glucose and 4% lactose supplemented with 0.5% FOS in B. breve. In survival assay, FOS supplementation (0.5-4%) in a 2% lactose system showed the highest positive effect on the cell viability of B. longum on day-10. As for B. breve, FOS supplementation (1 and 2%) in the 2% sucrose system showed the highest positive effect on the cell viability, followed by FOS supplementation (0.5, 3, and 4%) in 2% sucrose and FOS supplementation (3 and 4%) in 2% lactose on day-10. This study demonstrated that the efficacy of FOS supplementation was depended on its concentration, sugar system and its concentration, and Bifidobacterium strain.

The 16S rRNA gene is conserved across all bacteria and as such is routinely targeted in PCR surveys of bacterial diversity. PCR primer design aims to amplify as many different 16S rRNA gene sequences from as wide a range of organisms as possible, though there are no suitable 100% conserved regions of the gene, leading to bias. In the gastrointestinal tract, bifidobacteria are a key genus, but are often under-represented in 16S rRNA surveys of diversity. We have designed modified, ‘bifidobacteria-optimised’ universal primers, which we have demonstrated detection of bifidobacterial sequence present in DNA mixtures at 2% abundance, the lowest proportion tested. Optimisation did not compromise the detection of other organisms in infant faecal samples. Separate validation using fluorescence in situ hybridisation (FISH) shows that the proportions of bifidobacteria detected in faecal samples were in agreement with those obtained using 16S rRNA based pyrosequencing. For future studies looking at faecal microbiota, careful selection of primers will be key in order to ensure effective detection of bifidobacteria.

Probiotics means &quot;for life&quot;. Probiotics are naturally occurring beneficial organisms that aid in digestion and inhibit disease-causing bacteria in the intestine. Due to the beneficial impact of microorganism used as Probiotics; during the last decades progressive attention has been focused on biological and molecular characterization and improvement of such microbes during the last decades. Probiotics in the strictest sense, refers

Objective. To determine egg production in laying hens treated with oligofructose from agave. Materials and methods. Eighteen weeks old Hy-line W-36 hens (n=300) were distributed randomly into 3 treatment groups: no feed supplementation (control) or feed supplementation with 0.1% of 0.2% oligofructose from agave (OFA). Hens were monitored from development until 30 weeks of egg laying. Results. A significant (p<0.05) increase in the percent of egg-laying hens as well as increased in egg weight and egg quality occurred in hens from the OFA treatment groups relative to the control hens. Significantly lower levels (p<0.05) of fecal putrescine were observed in hens from the OFA treatment groups. Conclusions. The oligofructose from agave may be used as an alternative feed additive in laying hens.

Probiotics means “for life”. Probiotics are naturally occurring beneficial organisms that aid in digestion and inhibit disease-causing bacteria in the intestine. Due to the beneficial impact of microorganism used as Probiotics; during the last decades progressive attention has been focused on biological and molecular characterization and improvement of such microbes during the last decades. Probiotics in the strictest sense, refers to lactic acid producing bacteria Most data accumulated so far have related that lactic acid bacteria are major organisms, which that when given orally will pass through the strong acid of the stomach and the low surface tension of bile and colonize in the intestine, which is their normal habitat. Lactic acid bacteria mainly include Lactobacilli and Bifidobacteria. Various studies have indicated that lactobacillus species may have a positive influence on the intestinal flora of human, alleviate lactose intolerance, have hypocholesterolemic effect, stimula...

Diabetes mellitus is considered a global health problem which affects all sections of society, creating health and economy hardships. A large number of studies have identified risk factors that cause metabolic disorders such as genetic predisposition, unhealthy lifestyle, and altered gut microbiota. These factors are responsible for causing an increased adiposity, β-cell dysfunction, hyperglycemia, hypercholesterolemia, adiposity, dyslipidaemia, systemic inflammation, defective secretion of incretins and oxidative stress associated with type-2 diabetes (T2D). Probiotics particularly lactobacilli and bifidobacteria have recently emerged as the potential therapeutic agents with proven efficacy demonstrated in various in vitro and in vivo animal models adequately supported with their established multifunctional roles and mechanism of action for the prevention and disease treatment. The dietary management of DM by using probiotics is considered a novel strategy to slow development and p...

Objetivo. Determinar la producción de huevos en gallinas tratadas con oligofructosa de agave (OFA). Materiales y métodos. Se utilizaron 300 gallinas de la línea genética Hy-line w-36, de 18 semanas de nacidas, distribuidas aleatoriamente en tres tratamientos con cuatro repeticiones de 25 gallinas cada uno. Los tratamientos consistieron en tres niveles de OFA, 0, 0.1 y 0.2% en alimento. La prueba duró desde las 18 hasta las 30 semanas de postura. Resultados. Se presentó un incremento significativo (p&lt;0.05) en el porcentaje de postura y peso del huevo, así como en índices de calidad del huevo a favor de tratamientos con OFA. Se encontraron valores significativamente (p&lt;0.05) más bajos de putrescina fecal en las gallinas tratadas con OFA. Conclusiones. El uso de la OFA en gallinas ponedoras puede ser una alternativa como aditivo en la alimentación.

Objetivo. Determinar la producción de huevos en gallinas tratadas con oligofructosa de agave (OFA). Materiales y métodos. Se utilizaron 300 gallinas de la línea genética Hy-line w-36, de 18 semanas de nacidas, distribuidas aleatoriamente en tres tratamientos con cuatro repeticiones de 25 gallinas cada uno. Los tratamientos consistieron en tres niveles de OFA, 0, 0.1 y 0.2% en alimento. La prueba duró desde las 18 hasta las 30 semanas de postura. Resultados. Se presentó un incremento significativo (p&lt;0.05) en el porcentaje de postura y peso del huevo, así como en índices de calidad del huevo a favor de tratamientos con OFA. Se encontraron valores significativamente (p&lt;0.05) más bajos de putrescina fecal en las gallinas tratadas con OFA. Conclusiones. El uso de la OFA en gallinas ponedoras puede ser una alternativa como aditivo en la alimentación.

This review summarizes the nature, types, and properties of inulin polysaccharides and their applications as prebiotic dietary fibers. Natural food and commercial plant sources of inulin and extraction methods are presented. The physicochemical and functional properties of inulin are summarized. The prebiotic roles of inulin and their mechanisms of action are detailed. Inulin acts as prebiotic dietary fiber with multiple putative health benefits. It reduces caloric intake and contributes to reduced blood glucose and plasma lipid/cholesterol levels when used as sugar and fat replacers. It also stimulates immune systems and protects the colon mucosa against carcinogenesis and inflammation. Inulin also alters the composition and population of the gut microbiota. It stimulates the growth and activities of health beneficial microorganisms while inhibiting enteropathogenic bacteria. The beneficial microorganisms ferment inulin and produces acids including short-chain fatty acids that lower the pH in the colon and inhibit pathogens. The health beneficial bacteria also produce other metabolites that positively influence human health. The consumption of inulin is however, associated to symptoms of gastrointestinal discomfort, when consumed at higher levels to meet the daily recommendation of dietary fiber. Potential solutions to the limitations are forwarded as future research ideas and policy inputs.

In order to gain insight into the effects of human breast milk on the development of the intestinal bifidobacteria and associated health effects, the transcriptome of Bifidobacterium longum LMG 13197 grown in breast milk and formula milk containing galactooligosaccharides (GOS) and long-chain fructooligosaccharides was compared to that obtained in a semisynthetic medium with glucose. Total RNA was isolated from exponentially growing cells and hybridized to a clone library-based microarray. Inserts of clones with significant hybridization signals were sequenced and identified. The B. longum transcriptomes obtained during growth on human and formula milk were more similar to each other than to that obtained from growth in semisynthetic medium with glucose. Remarkably, there were only a few genes implicated in carbohydrate metabolism that were similarly upregulated during growth in both human and formula milk although oligosaccharides were added to the formula. Common highly upregulate...

Although their exact function remains enigmatic, bifidobacteria are among the first colonizers of the newborn infant gut and further develop into abundant communities, notably in response to diet. Therefore, the transcriptional responses of bifidobacteria in rapidly processed fecal samples from young infants that were fed either breast milk or a formula containing a mixture of galacto- and fructo-oligosaccharides were studied. The presence and diversity of the bifidobacterial fecal communities were determined using PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR for specific species. Changes in the total number of bifidobacteria as well as in species diversity were observed, indicating the metabolic activities of the bifidobacteria within the infant gut. In addition, total RNAs isolated from infant feces were labeled and hybridized to a bifidobacterium-specific microarray comprising approximately 6,000 clones of the major bifidobacterial species of the hum...